NKHXXIOFXDROOU-UHFFFAOYSA-N
C24H23F5N8O3S — CID 148642563
Data last refreshed: (MolForge compound catalog, from PubChem)
About NKHXXIOFXDROOU-UHFFFAOYSA-N
NKHXXIOFXDROOU-UHFFFAOYSA-N (PubChem CID 148642563) has the molecular formula C24H23F5N8O3S and a molecular weight of 598.56 g/mol. Its IUPAC name is N-[5-[3-fluoro-4-[4-[[(3-fluoro-2-pyridinyl)methylamino]-hydroxymethyl]triazol-1-yl]butyl]-1,3,4-thiadiazol-2-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide.
Molecular Properties
| Compound Name | NKHXXIOFXDROOU-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 148642563 |
| Molecular Formula | C24H23F5N8O3S |
| Molecular Weight | 598.56 g/mol |
| Exact Mass | 598.15 |
| IUPAC Name | N-[5-[3-fluoro-4-[4-[[(3-fluoro-2-pyridinyl)methylamino]-hydroxymethyl]triazol-1-yl]butyl]-1,3,4-thiadiazol-2-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide |
| SMILES | O=C(Cc1cccc(OC(F)(F)F)c1)Nc1nnc(CCC(F)Cn2cc(C(O)NCc3ncccc3F)nn2)s1 |
| InChI | InChI=1S/C24H23F5N8O3S/c25-15(12-37-13-19(33-36-37)22(39)31-11-18-17(26)5-2-8-30-18)6-7-21-34-35-23(41-21)32-20(38)10-14-3-1-4-16(9-14)40-24(27,28)29/h1-5,8-9,13,15,22,31,39H,6-7,10-12H2,(H,32,35,38) |
| InChIKey | NKHXXIOFXDROOU-UHFFFAOYSA-N |
| XLogP | 3.50 |
| TPSA | 139.97 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 598.56 |
| LogP ≤ 5 | 3.50 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 148642563 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.